Study Title: Randomized Phase II Trial of Postoperative Adjuvant Capecitabine and Temozolomide Versus Observation in High Risk Pancreatic Neuroendocrine Tumors
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Hawkins, William, at hawkinwi@musc.edu.Study Coordinator, Concepcion, Holly, at concepch@musc.edu.Trial opened at the following institutions: Medical University of South Carolina